Sign Out
Pergoveris is contraindicated in patients with: Hypersensitivity to the active substances follitropin α and lutropin α or to any of the excipients of Pergoveris.
Case of hypothalamus and pituitary gland tumours; ovarian enlargement or cyst not due to polycystic ovarian disease; gynaecological haemorrhages of unknown aetiology; ovarian, uterine or mammary carcinoma.
Pergoveris must not be used when an effective response cannot be obtained eg, primary ovarian failure, malformations of sexual organs incompatible with pregnancy and fibroid tumours of the uterus incompatible with pregnancy.
